BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37914889)

  • 1. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
    Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
    Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas.
    Ferrer-Torres D; Nancarrow DJ; Kuick R; Thomas DG; Nadal E; Lin J; Chang AC; Reddy RM; Orringer MB; Taylor JM; Wang TD; Beer DG
    Oncotarget; 2016 Aug; 7(34):54867-54882. PubMed ID: 27363029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction.
    Thrift AP; Nagle CM; Fahey PP; Smithers BM; Watson DI; Whiteman DC
    Cancer Causes Control; 2012 Apr; 23(4):555-64. PubMed ID: 22350865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
    Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
    J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.
    Jung KW; Talley NJ; Romero Y; Katzka DA; Schleck CD; Zinsmeister AR; Dunagan KT; Lutzke LS; Wu TT; Wang KK; Frederickson M; Geno DM; Locke GR; Prasad GA
    Am J Gastroenterol; 2011 Aug; 106(8):1447-55; quiz 1456. PubMed ID: 21483461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
    Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
    Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J
    Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction.
    Olsen CM; Pandeya N; Green AC; Webb PM; Whiteman DC;
    Am J Epidemiol; 2011 Sep; 174(5):582-90. PubMed ID: 21719746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
    Kamboj AK; Katzka DA; Iyer PG
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Risk in Barrett's Esophagus: A Clinical Review.
    Beydoun AS; Stabenau KA; Altman KW; Johnston N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.
    Rubenstein JH; Raghunathan T; Doan C; Schneider J; Zhao W; Metko V; Nofz K; Khodadost M; Corley DA
    Am J Gastroenterol; 2021 May; 116(5):949-957. PubMed ID: 33852454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.
    Matsuhashi N; Sakai E; Ohata K; Ishimura N; Fujisaki J; Shimizu T; Iijima K; Koike T; Endo T; Kikuchi T; Inayoshi T; Amano Y; Furuta T; Haruma K; Kinoshita Y
    J Gastroenterol Hepatol; 2017 Feb; 32(2):409-414. PubMed ID: 27416773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the Oesophagus and Oesophagogastric Junction: Analysis of Incidence and Risk Factors.
    Rantanen T; Oksala N; Sand J
    Anticancer Res; 2016 May; 36(5):2323-9. PubMed ID: 27127139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
    Sostres C; Lacarta P; Lanas A
    Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's Esophagus and esophageal adenocarcinoma.
    Bresalier RS
    Annu Rev Med; 2009; 60():221-31. PubMed ID: 18783330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
    Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
    Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction.
    Huang Q; Cheng Y; Lew E; Shi J; Wiener D; Weber HC
    J Dig Dis; 2023 Feb; 24(2):98-112. PubMed ID: 36970757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.